Immune checkpoint expression score is an independent prognostic biomarker in resectable non-small cell lung cancer

被引：0
|
作者：
Uso, Marta [1 ,2 ]
Jantus-Lewintre, Eloisa [2 ,3 ]
Sirera, Rafael [3 ]
Calabuig, Silvia [1 ,2 ]
Pastor, Enrique [4 ]
Forteza, Jeronimo [5 ]
Camps, Carlos [1 ,4 ]
机构：
[1] Univ Valencia, Valencia, Spain
[2] Fdn Invest Hosp Gen Univ Valencia, Valencia, Spain
[3] Univ Politecn Valencia, E-46022 Valencia, Spain
[4] Hosp Gen Univ Valencia, Valencia, Spain
[5] Inst Valenciano Patol, Valencia, Spain
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4330
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Immune checkpoint expression as prognostic biomarker candidates in non-small cell lung carcinoma patients
    Porto, Debora Maria
    Costa, Guilherme Jorge
    Torres, Leuridan Cavalcante
    Casarini, Dulce Elena
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 130 (04) : 919 - 928
  • [2] Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients
    Uso, Marta
    Jantus-Lewintre, Eloisa
    Calabuig-Farinas, Silvia
    Blasco, Ana
    Garcia del Olmo, Eva
    Guijarro, Ricardo
    Martorell, Miguel
    Camps, Carlos
    Sirera, Rafael
    ONCOIMMUNOLOGY, 2017, 6 (01):
  • [3] Value of the Glasgow Prognostic Score as a Prognostic Factor in Resectable Non-Small Cell Lung Cancer
    Yotsukura, Masaya
    Ohtsuka, Takashi
    Kaseda, Kaoru
    Kamiyama, Ikuo
    Hayashi, Yuichiro
    Asamura, Hisao
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (08) : 1311 - 1318
  • [4] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [5] Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
    Riano, Ivy
    Abuali, Inas
    Sharma, Aditya
    Durant, Jewelia
    Dragnev, Konstantin H. H.
    PHARMACEUTICALS, 2023, 16 (02)
  • [6] Prognostic Impact of Immune Cell Biomarkers in Surgically Resectable Non-Small Cell Lung Cancer
    Tuminello, S.
    Veluswamy, R.
    Petralia, F.
    Wang, P.
    Flores, R.
    Van Gerwen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S254 - S255
  • [7] INTRATUMOR VARIATION OF BIOMARKER EXPRESSION BY IMMUNOHISTOCHEMISTRY IN RESECTABLE NON-SMALL CELL LUNG CANCER
    Jakobsen, Jan N.
    Santoni-Rugiu, Eric
    Sorensen, Jens B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S471 - S471
  • [8] Intratumour variation of biomarker expression by immunohistochemistry in resectable non-small cell lung cancer
    Jakobsen, Jan Nyrop
    Santoni-Rugiu, Eric
    Ravn, Jesper
    Sorensen, Jens Benn
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (11) : 2494 - 2503
  • [9] Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer
    Tian, Yu
    Liu, Zhichao
    Pan, Hanbo
    Zhu, Hongda
    Zou, Ningyuan
    Jiang, Long
    Li, Ziming
    Huang, Jia
    Hu, Yingjie
    Luo, Qingquan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (04)
  • [10] Prognostic markers in resectable non-small cell lung cancer
    Strauss, GM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1997, 11 (03) : 409 - &
12345